Literature DB >> 7716790

Heavy metals and the etiology of Parkinson's disease and other movement disorders.

E B Montgomery1.   

Abstract

Heavy metals, such as iron and manganese, are involved in neurologic disease. Most often these diseases are associated with abnormal environmental exposures or abnormal accumulations of heavy metals in the body. There is increasing recognition that heavy metals normally present in the body also may play a role in disease pathogenesis through free radical formation. When a part of the brain known as the basal ganglia is affected, movements become disordered. Parkinson's disease is one of the most common movement disorders and is related to destruction of neurons in the substantia nigra pars compacta (SNpc) of the basal ganglia. The combination of high concentration of iron and the neurotransmitter, dopamine, may contribute to the selective vulnerability of the SNpc. Dopamine can auto-oxidize to produce free radicals particularly in the presence of iron and other heavy metals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7716790     DOI: 10.1016/0300-483x(94)02962-t

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  16 in total

1.  Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems.

Authors:  Allison W Willis; Bradley A Evanoff; Min Lian; Aiden Galarza; Andrew Wegrzyn; Mario Schootman; Brad A Racette
Journal:  Am J Epidemiol       Date:  2010-10-19       Impact factor: 4.897

2.  Involvement of NF kappa B in potentiated effect of Mn-containing dithiocarbamates on MPP(+) induced cell death.

Authors:  Cindi-Ann Williams; Ying Lin; Arlene Maynard; Shu-Yuan Cheng
Journal:  Cell Mol Neurobiol       Date:  2013-06-07       Impact factor: 5.046

3.  Cell-cycle arrest and inhibition of G1 cyclin translation by iron in AFT1-1(up) yeast.

Authors:  C C Philpott; J Rashford; Y Yamaguchi-Iwai; T A Rouault; A Dancis; R D Klausner
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

4.  Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

Authors:  Alexandre Benedetto; Catherine Au; Daiana Silva Avila; Dejan Milatovic; Michael Aschner
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

5.  Incorporating genetics and genomics in risk assessment for inhaled manganese: from data to policy.

Authors:  Christine P Curran; Robert M Park; Shuk-mei Ho; Erin N Haynes
Journal:  Neurotoxicology       Date:  2009-07-29       Impact factor: 4.294

Review 6.  Nrf2: a modulator of Parkinson's disease?

Authors:  Michael Todorovic; Stephen A Wood; George D Mellick
Journal:  J Neural Transm (Vienna)       Date:  2016-05-04       Impact factor: 3.575

Review 7.  Proteomic approach to studying Parkinson's disease.

Authors:  Jing Zhang; David R Goodlett
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

8.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

Review 9.  Mechanisms of Metal-Induced Mitochondrial Dysfunction in Neurological Disorders.

Authors:  Hong Cheng; Bobo Yang; Tao Ke; Shaojun Li; Xiaobo Yang; Michael Aschner; Pan Chen
Journal:  Toxics       Date:  2021-06-17

10.  Acid Precipitation and the Prevalence of Parkinson's Disease: An Ecologic Study in U.S. States.

Authors:  Gary G Schwartz; Mark R Williamson
Journal:  Brain Sci       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.